Form 10-Q · Quarterly report
ON Semiconductor 10-Q, filed Nov 2, 2026
- Filed
- CIK
- 0001097864
- Accession no.
- 0001097864-26-000021
Summary
ON Semiconductor reported quarterly revenue of $1,722.3 million, up about 11% year over year, and net income attributable to the company of $313.9 million for the quarter ended October 2, 2026, while continuing a manufacturing realignment program and pursuing its amended agreement to acquire Synaptics for $123.00 per share in cash, expected to close in mid-2027.
Key points
- Revenue rose about 11% year over year to $1,722.3 million for the quarter ended October 2, 2026, driven by industrial, AI data center and other end-markets, partly offset by lower automotive sales.
- Net income attributable to ON Semiconductor was $313.9 million, up from $255.0 million a year earlier.
- The amended Synaptics merger sets consideration at $123.00 per share in cash, with closing anticipated in mid-2027 and the FTC granting early termination of the HSR waiting period on August 12, 2026.
- The company recognized about $1.5 million in severance costs during the quarter under a manufacturing realignment program covering roughly 650 employee terminations.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Overview onsemi Overview ON Semiconductor Corporation ("onsemi," "we," "us," "our," or the "Company"), with its wholly and majority-owned subsidiaries, operates under the onsemiTM brand. The Company is organized into three operating and reportable segments: the Power Solutions Group ("PSG"), the Analog and Mixed-Signal Group ("AMG"), and the Intelligent Sensing Group ("ISG"). We deliver intelligent power and intelligent sensing technologies that enable electrification, energy efficiency, safety and automation across automotive, industrial and AI data center end-markets. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.